---
title: "Leerink Partners Reaffirms Their Buy Rating on Scholar Rock Holding (SRRK)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293043292.md"
description: "Leerink Partners reaffirmed its Buy rating on Scholar Rock Holding (SRRK) with a $59.00 price target. The broader analyst consensus for SRRK is a Strong Buy, with an average price target of $59.56."
datetime: "2026-07-17T12:55:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293043292.md)
  - [en](https://longbridge.com/en/news/293043292.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293043292.md)
generator: "portal-rs"
---

# Leerink Partners Reaffirms Their Buy Rating on Scholar Rock Holding (SRRK)

In a report released today, from Leerink Partners maintained a Buy rating on Scholar Rock Holding, with a price target of $59.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Currently, the analyst consensus on Scholar Rock Holding is a Strong Buy with an average price target of $59.56.

### Related Stocks

- [SRRK.US](https://longbridge.com/en/quote/SRRK.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)

## Related News & Research

- [Scholar Rock Provides Update on Global Apitegromab Regulatory Progress Across U.S., Europe, and Japan | SRRK Stock News](https://longbridge.com/en/news/296622602.md)
- [Scholar Rock to present at Cantor Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297181961.md)
- [Scholar Rock withdraws Europe filing for muscle weakness drug, plans resubmission](https://longbridge.com/en/news/296631683.md)
- [Key facts: ING Groep ADR (INGA) buys €53.09M shares; Reich resigns](https://longbridge.com/en/news/296872430.md)
- [Scholar Rock (NASDAQ:SRRK) Releases Earnings Results, Meets Estimates](https://longbridge.com/en/news/295175378.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**